Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-09-26
V
Venkatasai Devarapalli
Role not yet determined Is this you? Add your title
Also affiliated: Arkansas Children's Hospital (2026); Arkansas Children's Research Institute (2024)
1 h-index
4 pubs
2 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Venkatasai Devarapalli's research focuses on interventions for neonatal hypoglycemia, particularly the use of prophylactic dextrose gel. This work investigates strategies to prevent dangerously low blood glucose levels in newborns who are at risk. Devarapalli has collaborated with other researchers at the University of Arkansas for Medical Sciences, including Indirapriya Avulakunta, Vikramaditya Dumpa, Jared Beavers, and Jared Canonigo, on studies related to this area. Their publications explore the efficacy and application of dextrose gel as a preventive measure in neonatal care. Devarapalli's scholarly contributions, while early in their career, are centered on improving health outcomes for vulnerable infants.
Metrics
- h-index: 1
- Publications: 4
- Citations: 2
Selected Publications
-
Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU (2026)
-
Prophylactic dextrose gel use in newborns at risk for hypoglycemia (2024)
-
Prophylactic Dextrose Gel Use in Newborns at Risk for Hypoglycemia (2024)
Collaboration Network
Top Collaborators
Vikramaditya Dumpa
University of Arkansas Medical Center
2 shared publications
In database
- Prophylactic dextrose gel use in newborns at risk for hypoglycemia
- Prophylactic Dextrose Gel Use in Newborns at Risk for Hypoglycemia
Makenzie Niven
University of Arkansas for Medical Sciences
2 shared publications
In database
- Prophylactic dextrose gel use in newborns at risk for hypoglycemia
- Prophylactic Dextrose Gel Use in Newborns at Risk for Hypoglycemia
Jared Canonigo
University of Arkansas for Medical Sciences
2 shared publications
In database
- Prophylactic dextrose gel use in newborns at risk for hypoglycemia
- Prophylactic Dextrose Gel Use in Newborns at Risk for Hypoglycemia
Beverly J. Spray
Arkansas Children's Hospital (US)
2 shared publications
- Prophylactic dextrose gel use in newborns at risk for hypoglycemia
- Prophylactic Dextrose Gel Use in Newborns at Risk for Hypoglycemia
Indirapriya Avulakunta
University of Arkansas for Medical Sciences
2 shared publications
In database
- Prophylactic dextrose gel use in newborns at risk for hypoglycemia
- Prophylactic Dextrose Gel Use in Newborns at Risk for Hypoglycemia
Jared Beavers
University of Arkansas for Medical Sciences
2 shared publications
In database
- Prophylactic dextrose gel use in newborns at risk for hypoglycemia
- Prophylactic Dextrose Gel Use in Newborns at Risk for Hypoglycemia
Jennifer Andrews
University of Arkansas for Medical Sciences (US)
2 shared publications
- Prophylactic dextrose gel use in newborns at risk for hypoglycemia
- Prophylactic Dextrose Gel Use in Newborns at Risk for Hypoglycemia
Vonita Chawla
Arkansas Children's Hospital
1 shared publication
In database
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
Kumar Shashi
Arkansas Children's Hospital
1 shared publication
In database
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
Makenzie L. Niven
Southwestern Medical Center (US)
1 shared publication
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
Prachi Shah
Arkansas Children's Hospital
1 shared publication
In database
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
Andrew Tran
Arkansas Children's Hospital (US)
1 shared publication
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
Shelley E. Crary
Arkansas Children's Hospital
1 shared publication
In database
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
Matthew Merves
Arkansas Children's Hospital
1 shared publication
In database
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
Angela L. Chandler
Arkansas Children's Hospital
1 shared publication
In database
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
Similar Researchers
Based on overlapping research topics
Garrett Bannister
University of Arkansas at Fayetteville
Maternal and Perinatal Health Interventions
Healthcare Policy and Management
Birth, Development, and Health
Crystal Marcussen
University of Arkansas for Medical Sciences
Maternal and Perinatal Health Interventions
Healthcare Policy and Management
Birth, Development, and Health
Anna Guillory
University of Arkansas at Fayetteville
Maternal and Perinatal Health Interventions
Medical Case Studies
Birth, Development, and Health
J.W. Johnson
University of Arkansas for Medical Sciences
Maternal and Perinatal Health Interventions
Diet and metabolism studies
Birth, Development, and Health
Ryan Strebeck
University of Arkansas for Medical Sciences
Maternal and Perinatal Health Interventions
Medical Case Studies
Birth, Development, and Health
Caroline E. Crocker
University of Arkansas for Medical Sciences
Maternal and Perinatal Health Interventions
Medical Case Studies
Healthcare Policy and Management